Skip to content

Our Results

POC 1. Pilot trial in IBD: mean number of recruited patients/month

  • Data collected at Beaujon Hospital – Clichy, France
  • 12 trials (phase II, III and IV)
  • 42 months recruitment period : 21 before vs 21 with CT-SCOUT™
  • With CT-SCOUT™, the randomization rate is increased by 3 folds at both ICF signature and randomization

a ≠ b: p=0.01*
c ≠ d: p=0.02*

(*) Wilcoxon signed-rank test

Bouhnik Y et al. European Crohn’s Colitis Organisation (ECCO Congress)

Barcelona, Feb 2017

Download the chart

POC 2. Recruitment in ibd clinical trials depending on CT-SCOUT™ site equipment

Ulcerative Colitis

S/R : 307/149

Randomization increased by 4.0 folds in sites equipped with CT-SCOUT™

2019 12 17 16h30 09

Mann-Whitney test

Sites based in Belgium, France, Germany, Spain, UK and Israel

Bouhnik Y et al. UEGW, Oral communication,  Barcelona, 22th Oct. 2019

Download the chart

POC 3. Recruitment in ibd clinical trials depending on CT-SCOUT™ site equipment

Crohn’s disease

S/R : 337/140

Randomization increased by 1.9 folds in sites equipped with CT-SCOUT™

2019 12 17 16h34 34

Mann-Whitney test

Sites based in Belgium, France, Germany, Spain, UK and Israel

Bouhnik Y et al. UEGW, Oral communication,  Barcelona, 22th Oct. 2019

Download the chart

Testimony